Compare · KRMD vs SACH
KRMD vs SACH
Side-by-side comparison of KORU Medical Systems Inc. (KRMD) and Sachem Capital Corp. (SACH): market cap, price performance, sector, and recent activity on the wire.
Summary
- KRMD operates in Health Care, while SACH operates in Real Estate - the two are in different parts of the market.
- KRMD is the larger of the two at $188.8M, about 4.6x SACH ($41.0M).
- Over the past year, KRMD is up 18.0% and SACH is down 26.4% - KRMD leads by 44.4 points.
- KRMD has hit the wire 10 times in the past 4 weeks while SACH has been quiet.
- KRMD has more recent analyst coverage (6 ratings vs 5 for SACH).
- Company
- KORU Medical Systems Inc.
- Sachem Capital Corp.
- Price
- -
- -
- Market cap
- $188.8M
- $41.0M
- 1M return
- +3.80%
- -13.18%
- 1Y return
- +17.99%
- -26.43%
- Industry
- Medical/Dental Instruments
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- AMEX
- IPO
- 2017
- News (4w)
- 10
- 0
- Recent ratings
- 6
- 5
KORU Medical Systems Inc.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Sachem Capital Corp.
Sachem Capital Corp. operates as a real estate finance company. The company is involved in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located primarily in Connecticut. It offers loans to real estate investors to fund their acquisition, renovation, rehabilitation, development, and/or improvement of residential or commercial properties. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Sachem Capital Corp. was founded in 2010 and is based in Branford, Connecticut.
Latest KRMD
- KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
- Amendment: SEC Form 4 filed by President and CEO Kalbermatten Adam R
- SEC Form 4 filed by President and CEO Kalbermatten Adam R
- Director Wholihan Edward was granted 3,571 shares, increasing direct ownership by 7% to 51,312 units (SEC Form 4)
- Director Matin Shahriar was granted 3,571 shares, increasing direct ownership by 4% to 101,144 units (SEC Form 4)
- Director French Donna was granted 3,571 shares, increasing direct ownership by 4% to 98,514 units (SEC Form 4)
- Chairman of the Board Fletcher R John was granted 5,357 shares, increasing direct ownership by 2% to 232,157 units (SEC Form 4)
- Director Cascella Robert was granted 3,571 shares, increasing direct ownership by 4% to 98,155 units (SEC Form 4)
- Director Manko Joseph M. Jr. was granted 3,571 shares (SEC Form 4)
- KORU Medical Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Latest SACH
- Sachem Capital Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Sachem Capital Corp. Announces Common and Preferred Dividends
- Sachem Capital Mourns the Passing of Board Member Arthur Goldberg
- SEC Form DEFA14A filed by Sachem Capital Corp.
- Sachem Capital Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Sachem Capital Reports First Quarter 2026 Results
- SEC Form 10-Q filed by Sachem Capital Corp.
- SEC Form DEFA14A filed by Sachem Capital Corp.
- SEC Form NT 10-Q filed by Sachem Capital Corp.
- SEC Form DEFA14A filed by Sachem Capital Corp.